Addition of P1101 to Imatinib Treatment in Patients With Chronic Phase Chronic Myeloid Leukaemia Not Achieving a Complete Molecular Response
Clinical trial NCT01933906 · COMPLETED
Trial details
- NCT number
- NCT01933906
- Sponsor
- Arbeitsgemeinschaft medikamentoese Tumortherapie
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-08-30
- Primary completion
- 2018-11-14
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.